{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T05:06:46Z","timestamp":1794978406374,"version":"4.9.1"},"reference-count":34,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"\u201cVictor Babes\u201d University of Medicine and Pharmacy Timisoara"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Dysglycemia is a major determinant of adverse outcomes in COVID-19, yet the separate contributions of poor glycemic control and glycemic variability (GV) remain incompletely defined. We conducted a systematic review and meta-analysis of observational cohort studies (both prospective and retrospective) to quantify the impact of chronic hyperglycemia and glucose instability on disease severity, intensive care requirements, and mortality in patients with COVID-19. Materials and Methods: We searched PubMed, Scopus, and Web of Science from January 2020 to October 2024 for observational cohort studies reporting clinically relevant COVID-19 outcomes stratified by glycemic control or GV. Dysglycemia definitions varied across studies (HbA1c-based chronic hyperglycemia, fasting glucose, or admission\/in-hospital hyperglycemia). GV was assessed using metrics including mean amplitude of glycemic excursions (MAGE), standard deviation (SD), coefficient of variation (CV), or maximum daily glucose difference. Twelve studies met inclusion criteria and were included in qualitative synthesis; five studies were eligible for quantitative synthesis of clinical outcomes. Random-effects DerSimonian\u2013Laird models were applied due to anticipated clinical heterogeneity. Heterogeneity was evaluated using Cochran\u2019s Q, \u03c42, and I2 statistics. Results: Overall, 12 observational studies (9 prospective and 3 retrospective cohorts; n = 1,008,310 patients) were included. In quantitative analyses of five eligible cohorts, poor glycemic control was associated with a significantly increased risk of severe or critical COVID-19 (pooled RR = 1.75, 95% CI: 1.45\u20132.11; I2 = 29%), ICU admission (RR = 1.54, 95% CI: 1.18\u20132.01), and mechanical ventilation (RR = 1.72, 95% CI: 1.31\u20132.26). Three studies evaluating GV demonstrated a strong association with adverse outcomes (pooled RR = 2.07, 95% CI: 1.71\u20132.50; I2 = 0%); this low heterogeneity should be interpreted cautiously given the limited number of studies. GV remained associated with mortality in multivariable models, indicating that glycemic variability is separately associated with mortality as a clinically relevant prognostic risk marker in hospitalized COVID-19 patients. Conclusions: Both chronic hyperglycemia and elevated glycemic variability are each associated with increased risk of severe COVID-19 outcomes. Glycemic variability appeared to be a consistent, low-heterogeneity prognostic marker of mortality, being separately associated with higher death risk in hospitalized COVID-19 patients, highlighting its potential utility as a dynamic metabolic biomarker. Early identification and targeted management of dysglycemia\u2014especially glucose instability\u2014may improve prognosis in hospitalized COVID-19 patients. PROSPERO: CRD420251250718.<\/jats:p>","DOI":"10.3390\/medicina62020310","type":"journal-article","created":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T15:38:12Z","timestamp":1770046692000},"page":"310","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Association of Chronic Hyperglycemia and Glycemic Variability with Mortality in COVID-19: Meta-Analysis of Cohort Studies"],"prefix":"10.3390","volume":"62","author":[{"given":"Ana-Maria","family":"Pah","sequence":"first","affiliation":[{"name":"Cardiology Department, \u201cVictor Babes\u201d University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timi\u015foara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dragos-Mihai","family":"Gavrilescu","sequence":"additional","affiliation":[{"name":"Department of Orthodontics, Dental District, Strada Z\u0103gazului Nr. 3, ONE Floreasca Vista, Sector 1, 014261 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4951-1702","authenticated-orcid":false,"given":"Diana-Maria","family":"Mateescu","sequence":"additional","affiliation":[{"name":"Doctoral School, Department of General Medicine, \u201cVictor Babes\u201d University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioana-Georgiana","family":"Cotet","sequence":"additional","affiliation":[{"name":"Doctoral School, Department of General Medicine, \u201cVictor Babes\u201d University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Laura","family":"Craciun","sequence":"additional","affiliation":[{"name":"Cardiology Department, \u201cVictor Babes\u201d University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timi\u015foara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard","family":"Florescu","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, \u201cVictor Babes\u201d Infectious Diseases and Pulmonology Clinical Hospital, 13 Gheorghe Adam Street, 300310 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8760-5605","authenticated-orcid":false,"given":"Simina","family":"Crisan","sequence":"additional","affiliation":[{"name":"Cardiology Department, \u201cVictor Babes\u201d University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timi\u015foara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7868-9266","authenticated-orcid":false,"given":"Adina","family":"Avram","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, \u201cVictor Babes\u201d University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,2,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S2213-8587(20)30272-2","article-title":"Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England","volume":"8","author":"Barron","year":"2020","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S2213-8587(20)30271-0","article-title":"Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in the UK","volume":"8","author":"Holman","year":"2020","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_3","first-page":"303","article-title":"Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes","volume":"43","author":"Cariou","year":"2020","journal-title":"Diabetes Care"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S2213-8587(20)30238-2","article-title":"COVID-19 in people with diabetes: Understanding the reasons for worse outcomes","volume":"8","author":"Apicella","year":"2020","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000345107","article-title":"Diabetes and infection: Is there a link? A mini-review","volume":"59","author":"Knapp","year":"2013","journal-title":"Gerontology"},{"key":"ref_6","first-page":"442","article-title":"Type 2 diabetes mellitus and its impact on the immune system","volume":"16","author":"Berbudi","year":"2020","journal-title":"Curr. Diabetes Rev."},{"key":"ref_7","first-page":"108","article-title":"Hyperglycemia and COVID-19: What was known and what is new?","volume":"164","author":"Ceriello","year":"2020","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.2337\/dc20-0723","article-title":"Outcomes in patients with hyperglycemia affected by COVID-19: Can we do more on glycemic control?","volume":"43","author":"Sardu","year":"2020","journal-title":"Diabetes Care"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1056\/NEJMc2018688","article-title":"New-onset diabetes in COVID-19","volume":"383","author":"Rubino","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s42255-021-00347-1","article-title":"SARS-CoV-2 infects and replicates in pancreatic endocrine cells","volume":"3","author":"Conzelmann","year":"2021","journal-title":"Nat. Metab."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/s42255-021-00407-6","article-title":"Acute and long-term disruption of glycometabolic control in COVID-19 patients","volume":"3","author":"Montefusco","year":"2021","journal-title":"Nat. Metab."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.diabres.2012.12.023","article-title":"The high incidence of steroid-induced hyperglycaemia in hospital","volume":"99","author":"Fong","year":"2013","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1111\/dom.14269","article-title":"Proportion of newly diagnosed diabetes in COVID-19 patients: A systematic review and meta-analysis","volume":"23","author":"Sathish","year":"2021","journal-title":"Diabetes Obes. Metab."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/all.14657","article-title":"Risk factors for severe and critically ill COVID-19 patients: A review","volume":"76","author":"Gao","year":"2021","journal-title":"Allergy"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Boroumand, A.B., Forouhi, M., Gholami, A., Hashemi, R., Sikaroudi, M., Saadati, H., Shabani, M., Ostovan, M., Sikaroudi, M.K., and Mardani, A. (2022). Immunogenicity of COVID-19 vaccines in patients with diabetes mellitus: A systematic review. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.940357"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref_17","unstructured":"Wells, G.A., Shea, B., O\u2019Connell, D., Peterson, J., Welch, V., Losos, M., and Tugwell, P. (2025, December 01). The Newcastle\u2013Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses. Available online: http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias","volume":"50","author":"Begg","year":"1994","journal-title":"Biometrics"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s13098-023-01157-z","article-title":"Association between inpatient glycemic variability and COVID-19 mortality: A prospective study","volume":"15","author":"Parolin","year":"2023","journal-title":"Diabetol. Metab. Syndr."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1007\/s13410-020-00880-x","article-title":"Improved glycemic control amongst people with long-standing diabetes during COVID-19 lockdown: A prospective, observational, nested cohort study","volume":"40","author":"Rastogi","year":"2020","journal-title":"Int. J. Diabetes Dev. Ctries."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1007\/s40200-021-00922-z","article-title":"The effect of underlying diabetes disease on clinical outcome and survival in patients with COVID-19: A propensity score matching study","volume":"20","author":"Ghadamgahi","year":"2021","journal-title":"J. Diabetes Metab. Disord."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1038\/s41467-022-30068-2","article-title":"Glycaemic control is associated with SARS-CoV-2 breakthrough infections in vaccinated patients with type 2 diabetes","volume":"13","author":"Marfella","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1111\/dom.14643","article-title":"Humoral immune response to COVID-19 vaccination in diabetes is age-dependent but independent of type of diabetes and glycaemic control: The prospective COVAC-DM cohort study","volume":"24","author":"Sourij","year":"2022","journal-title":"Diabetes Obes. Metab."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/dom.16071","article-title":"Incidence of diabetes mellitus following hospitalisation for COVID-19 in the United Kingdom: A prospective observational study","volume":"27","author":"Tyrer","year":"2025","journal-title":"Diabetes Obes. Metab."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/qjmed\/hcac020","article-title":"Short and long-term prognosis of glycemic control in COVID-19 patients with type 2 diabetes","volume":"115","author":"Zhan","year":"2022","journal-title":"QJM"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1186\/s13098-023-01228-1","article-title":"Hyperglycemia and glucose variability are associated with worse survival in mechanically ventilated COVID-19 patients: The prospective Maastricht Intensive Care Covid Cohort","volume":"15","author":"Driessen","year":"2023","journal-title":"Diabetol. Metab. Syndr."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"6243","DOI":"10.4103\/jfmpc.jfmpc_709_22","article-title":"Effect of SARS-CoV-2 on glycemic control in post-COVID-19 diabetic patients","volume":"11","author":"Yadaiah","year":"2022","journal-title":"J. Fam. Med. Prim. Care"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"154344","DOI":"10.1016\/j.metabol.2020.154344","article-title":"Diabetes, glycaemic control, and risk of COVID-19 hospitalisation: Population-based, prospective cohort study","volume":"112","author":"Hamer","year":"2020","journal-title":"Metabolism"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.dsx.2020.05.037","article-title":"Does poor glucose control increase the severity and mortality in patients with diabetes and COVID-19?","volume":"14","author":"Singh","year":"2020","journal-title":"Diabetes Metab. Syndr."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1111\/dom.14659","article-title":"Risk of new-onset type 2 diabetes mellitus in 600,055 persons after COVID-19: A cohort study","volume":"24","author":"Birabaharan","year":"2022","journal-title":"Diabetes Obes. Metab."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Wang, X., and Cao, Y. (2025). A Narrative Review: Relationship Between Glycemic Variability and Emerging Complications of Diabetes Mellitus. Biomolecules, 15.","DOI":"10.3390\/biom15020188"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Yamaguchi, H., and Yamaguchi, H. (2025). Oxidative and Glycation Stress Biomarkers: Advances in Detection Technologies and Point-of-Care Clinical Applications. Molecules, 30.","DOI":"10.3390\/molecules30214286"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Zhao, X., Jiang, L., Sun, W., Tang, S., Kang, X., Gao, Q., Li, Z., An, X., and Lian, F. (2025). Understanding the interplay between COVID-19 and diabetes: Insights for the post-pandemic era. Front. Endocrinol., 16.","DOI":"10.3389\/fendo.2025.1599969"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/2\/310\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T16:06:54Z","timestamp":1770048414000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/2\/310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,2]]},"references-count":34,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["medicina62020310"],"URL":"https:\/\/doi.org\/10.3390\/medicina62020310","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,2]]}}}